Bones Home > Didronel Uses
Several bone conditions can be treated with Didronel. Uses of the medication specifically include the treatment of Paget's disease and abnormal bone formation after spinal cord injury or total hip replacement. At this time, the drug is not approved for use in children. Healthcare providers may also occasionally recommend off-label Didronel uses, such as for treating osteoporosis.
Didronel® (etidronate disodium) is a prescription medication that is part of a group of medications known as bisphosphonates. It is approved for the following uses:
- To prevent and treat abnormal bone formation (known medically as heterotopic ossification) after total hip replacement surgery or spinal cord injury
- To treat Paget's disease of bone.
Heterotopic ossification is the medical term for bone formation in abnormal places (such as in muscle tissue). Heterotopic ossification can lead to extreme pain and loss of mobility and function. It is not known exactly how or why heterotopic ossification occurs, but it often occurs after an injury. Heterotopic ossification is a common complication that occurs after total hip replacement surgery or injury to the spinal cord. The hip is one of the most common places for this abnormal bone formation to occur. When caused by spinal cord injury, the abnormal bone always forms below the level of spinal cord injury.
Not all cases of heterotopic ossification are severe enough to cause symptoms or to require treatment. Treatment for this condition usually includes Didronel and nonsteroidal anti-inflammatory drugs (NSAIDs), and sometimes surgery is necessary to remove the abnormal bone. Didronel is approved to prevent heterotopic ossification due to total hip replacement surgery or spinal cord injury. It is also approved to treat heterotopic ossification that has already started. However, Didronel is not useful for treating abnormal bone that has already fully formed (known as mature heterotopic ossification).